These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28692133)

  • 1. New insights into enterocin CRL35: mechanism of action and immunity revealed by heterologous expression in Escherichia coli.
    Barraza DE; Ríos Colombo NS; Galván AE; Acuña L; Minahk CJ; Bellomio A; Chalón MC
    Mol Microbiol; 2017 Sep; 105(6):922-933. PubMed ID: 28692133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of the class IIa bacteriocin receptor function and membrane structural changes are associated to enterocin CRL35 high resistance in Listeria monocytogenes.
    Masias E; Dupuy FG; da Silva Sanches PR; Farizano JV; Cilli E; Bellomio A; Saavedra L; Minahk C
    Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1770-1776. PubMed ID: 28323072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The case for class II bacteriocins: A biophysical approach using "suicide probes" in receptor-free hosts to study their mechanism of action.
    Ríos Colombo NS; Chalón MC; Dupuy FG; Gonzalez CF; Bellomio A
    Biochimie; 2019 Oct; 165():183-195. PubMed ID: 31381962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short peptides derived from the NH2-terminus of subclass IIa bacteriocin enterocin CRL35 show antimicrobial activity.
    Salvucci E; Saavedra L; Sesma F
    J Antimicrob Chemother; 2007 Jun; 59(6):1102-8. PubMed ID: 17449885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effect of synthetic enterocin CRL35 with cell wall, membrane-acting antibiotics and muranolytic enzymes against Listeria cells.
    Salvucci E; Hebert EM; Sesma F; Saavedra L
    Lett Appl Microbiol; 2010 Aug; 51(2):191-5. PubMed ID: 20672439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriocin enterocin CRL35 is a modular peptide that induces non-bilayer states in bacterial model membranes.
    Medina Amado C; Minahk CJ; Cilli E; Oliveira RG; Dupuy FG
    Biochim Biophys Acta Biomembr; 2020 Feb; 1862(2):183135. PubMed ID: 31738901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane viscosity is a major modulating factor of the enterocin CRL35 activity.
    Minahk CJ; Saavedra L; Sesma F; Morero R
    Biochimie; 2005 Feb; 87(2):181-6. PubMed ID: 15760710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of enterocin CRL35 on Listeria monocytogenes cell membrane.
    Minahk CJ; Farías ME; Sesma F; Morero RD
    FEMS Microbiol Lett; 2000 Nov; 192(1):79-83. PubMed ID: 11040432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous expression of enterocin A, a bacteriocin from Enterococcus faecium, fused to a cellulose-binding domain in Escherichia coli results in a functional protein with inhibitory activity against Listeria.
    Klocke M; Mundt K; Idler F; Jung S; Backhausen JE
    Appl Microbiol Biotechnol; 2005 Jun; 67(4):532-8. PubMed ID: 15660219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of antibiotic activity by sub-lethal concentrations of enterocin CRL35.
    Minahk CJ; Dupuy F; Morero RD
    J Antimicrob Chemother; 2004 Feb; 53(2):240-6. PubMed ID: 14729738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and expression of synthetic genes encoding native, hybrid- and bacteriocin-derived chimeras from mature class IIa bacteriocins, by Pichia pastoris (syn. Komagataella spp.).
    Arbulu S; Jiménez JJ; Gútiez L; Feito J; Cintas LM; Herranz C; Hernández PE
    Food Res Int; 2019 Jul; 121():888-899. PubMed ID: 31108822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PrfA activation in Listeria monocytogenes increases the sensitivity to class IIa bacteriocins despite impaired expression of the bacteriocin receptor.
    Farizano JV; Masías E; Hsu FF; Salomón RA; Freitag NE; Hebert EM; Minahk C; Saavedra L
    Biochim Biophys Acta Gen Subj; 2019 Aug; 1863(8):1283-1291. PubMed ID: 31059750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Basis of the Mechanisms of Action and Immunity of Lactococcin A, a Class IId Bacteriocin.
    Li R; Duan J; Zhou Y; Wang J
    Appl Environ Microbiol; 2023 Mar; 89(3):e0006623. PubMed ID: 36840592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 28-mer Fragment Derived from Enterocin CRL35 Displays an Unexpected Bactericidal Effect on Listeria Cells.
    Masias E; Sanches PR; Dupuy FG; Acuna L; Bellomio A; Cilli E; Saavedra L; Minahk C
    Protein Pept Lett; 2015; 22(6):482-8. PubMed ID: 25962066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the enterocin CRL35 activity by a synthetic peptide derived from the NH2-terminal sequence.
    Saavedra L; Minahk C; de Ruiz Holgado AP; Sesma F
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2778-81. PubMed ID: 15215149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enterocin CRL35 inhibits Listeria monocytogenes in a murine model.
    Salvucci E; Saavedra L; Hebert EM; Haro C; Sesma F
    Foodborne Pathog Dis; 2012 Jan; 9(1):68-74. PubMed ID: 22011041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning, overexpression, purification of bacteriocin enterocin-B and structural analysis, interaction determination of enterocin-A, B against pathogenic bacteria and human cancer cells.
    Ankaiah D; Palanichamy E; Antonyraj CB; Ayyanna R; Perumal V; Ahamed SIB; Arul V
    Int J Biol Macromol; 2018 Sep; 116():502-512. PubMed ID: 29729340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common mechanisms of target cell recognition and immunity for class II bacteriocins.
    Diep DB; Skaugen M; Salehian Z; Holo H; Nes IF
    Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2384-9. PubMed ID: 17284603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotechnological use of dairy by-products for the production and microencapsulation of the food preservative enterocin CRL35.
    Farizano JV; Díaz Vergara LI; Masias E; Baillo AA; Torino MI; Fadda S; Vanden Braber NL; Montenegro MA; Saavedra L; Minahk C
    FEMS Microbiol Lett; 2022 Apr; 369(1):. PubMed ID: 35325116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriocin release proteins: mode of action, structure, and biotechnological application.
    van der Wal FJ; Luirink J; Oudega B
    FEMS Microbiol Rev; 1995 Dec; 17(4):381-99. PubMed ID: 8845188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.